ELTX · Elicio Therapeutics, Inc.
$2.89
-0.06 (-2.03%)
At close · Jul 29
Market Cap
$55.16M
Shares
19.09M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-30 | 49,851 | $4.00 | $199,404 |
| 2026-06-29 | 48,351 | $4.00 | $193,404 |
| 2026-06-26 | 3,555 | $3.75 | $13,331 |
| 2026-06-25 | 14,359 | $3.98 | $57,149 |
| 2026-06-24 | 61,410 | $4.11 | $252,395 |
| 2026-06-23 | 668,142 | $4.14 | $2,766,108 |
| 2026-06-22 | 1,437,702 | $3.85 | $5,535,153 |
| 2026-06-18 | 660,446 | $4.71 | $3,110,701 |
| 2026-06-17 | 422,002 | $2.76 | $1,164,726 |
| 2026-06-16 | 360,846 | $4.08 | $1,472,252 |
| 2026-06-15 | 8,642 | $14.85 | $128,334 |
| 2026-06-12 | 1,300 | $13.94 | $18,122 |
| 2026-06-11 | 51,492 | $14.30 | $736,336 |
| 2026-06-09 | 12,143 | $13.55 | $164,538 |
| 2026-06-08 | 6,569 | $13.26 | $87,105 |
| 2026-06-05 | 7,738 | $13.93 | $107,790 |
| 2026-06-04 | 14,618 | $12.53 | $183,164 |
| 2026-06-03 | 3,626 | $11.49 | $41,663 |
| 2026-06-01 | 1,400 | $11.44 | $16,016 |
| 2026-05-29 | 362 | $10.61 | $3,841 |
| 2026-05-28 | 388 | $10.77 | $4,179 |
| 2026-05-27 | 15,034 | $10.03 | $150,791 |
| 2026-05-26 | 1,845 | $9.95 | $18,358 |
| 2026-05-21 | 2,259 | $9.97 | $22,522 |
| 2026-05-20 | 1,415 | $9.17 | $12,976 |
| 2026-05-19 | 10,034 | $9.57 | $96,025 |
| 2026-05-18 | 6,267 | $10.63 | $66,618 |
| 2026-05-14 | 25,514 | $11.30 | $288,308 |
| 2026-05-13 | 1,824 | $10.55 | $19,243 |
| 2026-05-12 | 61,210 | $11.61 | $710,648 |
| 2026-05-11 | 6,510 | $9.91 | $64,514 |
| 2026-05-07 | 3,888 | $10.45 | $40,630 |
| 2026-05-06 | 5,985 | $10.59 | $63,381 |
| 2026-05-05 | 226 | $10.77 | $2,434 |
| 2026-05-04 | 9,585 | $10.75 | $103,039 |
| 2026-05-01 | 5,067 | $10.62 | $53,812 |
Showing 1–36 of 36 settlements
Key facts
CIK
1601485
CUSIP
28657F103
13F (30d)
11 filings
11 filers
Visit website
Investor relations